Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain.
Clinical trial NCT04304508 · COMPLETED
Trial details
- NCT number
- NCT04304508
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-15
- Primary completion
- 2022-02-18
- Enrollment
- 1808
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.